bullish

Sanofi India

Sanofi India - Steady Numbers, Margins Improve QoQ; Focus on Growth of Power Brands…

104 Views08 Nov 2022 06:31
Broker
Sanofi offers drugs in therapies like diabetes (insulins & orals), cardiology, pain, allergy and epilepsy. Around 70% of sales stem from top seven brands.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 15-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
ICICI Securities Limited
External broker reports(aggregated public sources)
ICICI Securities Ltd
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Sanofi India - Steady Numbers, Margins Improve QoQ; Focus on Growth of Power Brands…
    08 Nov 2022
x